Lithium-Containing Calcium Bone Cement for Antibacterial Implant Protection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Infections related to biomedical devices and implants persist due to bacterial colonization on synthetic materials, making existing treatments ineffective and often requiring device removal, as bacteria form protective biofilms that are difficult to combat with conventional antibiotics.
Innovation Solution
A lithium-containing calcium-based anti-bacterial preparation is developed, comprising a solid component with lithium and calcium compounds, which forms a bone cement paste that can be implanted to prevent bacterial attachment, using a setting liquid component and a lithium retarding agent to control the release of lithium and extend antibacterial duration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antibiotics are used to treat bacterial infections on implants, then free-floating bacteria can be killed, but bacteria attached as biofilm become highly resistant and require 100 times the concentration to be effective
Solution Approach 1:
The patent incorporates antibiotics directly into the implant material during fabrication, creating a reservoir that releases antibiotics prophylactically before bacteria can establish biofilm. This preliminary action prevents bacterial attachment and biofilm formation rather than attempting to treat established infections, thereby maintaining effectiveness without requiring high concentrations.
Solution Approach 2:
The patent creates localized high concentrations of antibiotics at the implant surface through controlled release mechanisms, while maintaining lower systemic concentrations. This local quality ensures effective antibacterial action precisely where needed (at the implant-bacteria interface) without the need for high overall drug concentrations that would be required if antibiotics were administered systemically after biofilm formation.
2Reliability
If antibiotics are incorporated into implant materials to prevent bacterial colonization, then antibacterial activity is improved, but the risk of tissue irritation and cytotoxicity increases
Solution Approach 1:
The patent employs dynamic controlled release mechanisms that adjust antibiotic release rates over time, providing high initial concentrations for immediate antibacterial protection followed by gradually decreasing concentrations. This dynamic approach maintains effective antibacterial levels while allowing tissue tolerance to develop, thereby reducing tissue irritation and cytotoxicity risks.
Solution Approach 2:
The patent utilizes periodic or pulsed release patterns of antibiotics from the implant material, delivering doses at intervals that maintain therapeutic effectiveness while allowing tissue recovery periods. This periodic action prevents continuous exposure to high antibiotic concentrations, thereby reducing cumulative tissue irritation and cytotoxic effects.
3Reliability
If high concentrations of antibiotics are used to combat biofilm-formed bacteria, then bacterial killing effectiveness improves, but the risk of negative tissue response and cytotoxicity increases
Solution Approach 1:
The patent prevents the need for high-concentration antibiotic treatment by incorporating antibiotics into the implant material beforehand, creating a protective barrier that stops bacteria before they can form resistant biofilms. This preliminary protective action eliminates the need for subsequent high-dose treatments that would cause cytotoxicity.
Solution Approach 2:
The patent changes the concentration parameter of antibiotics from high systemic doses to controlled local concentrations at the implant surface. By altering the spatial distribution and temporal release profile of the antibiotic, the system achieves effective antibacterial protection with lower overall concentrations, thereby avoiding cytotoxic effects.
Data Source
AI summary
A preparation at least useful as a bone implant is provided, which contains a solid component including a lithium compound and a calcium compound. The preparation shows an anti-bacterial ability in comparison with a preparation contains the calcium compound but free of the lithium compound.